Fig. 4: Conjugated BAs and BA deconjugation potentials differ in SZ patients with first (F-SZ) versus recurrent episodes (R-SZ).
From: Targeted metabolomics reveals aberrant profiles of serum bile acids in patients with schizophrenia
Scatter box plots for total conjugated BAs, glycine conjugated BAs and taurine conjugated BAs (A), and deconjugation potentials of CA, CDCA, and UDCA (B). The comparisons between the two groups were conducted by the Mann–Whitney U tests, excluding outliers. *p < 0.05.
